Glaxo and Alphabet forge $715-million bioelectronic medicines firm

Publication Title
The Globe and Mail
Publication/Creation Date
August 1 2016
Kris Famm (creator)
Moncef Slaoui (creator)
Persuasive Intent
GlaxoSmithKline and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.
HCI Platform
Location on Body

Date archived
August 3 2016
Last edited
August 24 2016
How to cite this entry
Kris Famm, Moncef Slaoui. (August 1 2016). "Glaxo and Alphabet forge $715-million bioelectronic medicines firm". The Globe and Mail. Fabric of Digital Life.